Cdc20B Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc20B monoclonal antibodies for research in cell cycle regulation and mitotic processes. Cdc20B monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc20B is a crucial activator of the anaphase-promoting complex/cyclosome (APC/C), playing a significant role in the regulation of the cell cycle by promoting the degradation of specific proteins that inhibit progression to anaphase. Its proper function is essential for maintaining genomic stability and preventing uncontrolled cell division, which can lead to tumorigenesis. Understanding the role of Cdc20B in cellular processes is vital for advancing cancer research and therapeutic strategies. Researchers can utilize Cdc20B monoclonal antibodies to investigate cell cycle checkpoints and their impact on cellular division. The high specificity of Cdc20B monoclonal antibodies enables precise detection and analysis of protein expression patterns across various experimental conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cell cycle regulation and its implications in human health.